Novartis partnered with Conatus soon after results of this small NASH trial, which are certainly no better than our results (no LPS, 30-something patients, also no reduction in liver fat) with $50,000,000 USD up front. https://ir.conatuspharma.com/news-r...uccessful-top-line-results-nafldnash-clinical
- Forums
- ASX - By Stock
- IMC
- Conatus & Novartis
IMC
immuron limited
Add to My Watchlist
6.06%
!
3.5¢
Conatus & Novartis
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
The Watchlist
OR3
ORE RESOURCES LIMITED
Nick Rathjen, Managing Director
Nick Rathjen
Managing Director
SPONSORED BY The Market Online
